Terms: = Lung cancer AND DDX10, HRH-J8, 1662, ENSG00000178105, Q13206 AND Treatment
5 results:
1. Tumor mutation burden for predicting immune checkpoint blockade response: the more, the better.
Zheng M
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35101940
[TBL] [Abstract] [Full Text] [Related]
2. ddx10 promotes human lung carcinoma proliferation by U3 small nucleolar ribonucleoprotein IMP4.
Liu C; Tang J; Duan X; Du Y; Wang X; Cui Y
Thorac Cancer; 2021 Jun; 12(12):1873-1880. PubMed ID: 33973712
[TBL] [Abstract] [Full Text] [Related]
3. Associations between muscle measures, survival, and toxicity in patients with limited stage small cell lung cancer.
Halvorsen TO; Valan CD; Slaaen M; Grønberg BH
J Cachexia Sarcopenia Muscle; 2020 Oct; 11(5):1283-1290. PubMed ID: 32725772
[TBL] [Abstract] [Full Text] [Related]
4. Comparative analysis between combination and single-agent chemotherapy for elderly patients with advanced non-small cell lung cancer: A nationwide population-based outcome study.
Lee YG; Lee JH; Kim SH; Kim YJ; Lee H; Ahn S; Jang JS; Lee JS; Kim JH
Lung Cancer; 2018 Aug; 122():88-93. PubMed ID: 30032852
[TBL] [Abstract] [Full Text] [Related]
5. [Total spondylectomy and reconstruction for thoracolumbar spinal tumors with neurological deficit].
Zeng J; Liu H; Song Y
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 May; 21(5):445-8. PubMed ID: 17578278
[TBL] [Abstract] [Full Text] [Related]
